Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

SARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive seasonal coronavirus antibodies and compare the rate of anti...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Ratcliffe, H, Tiley, K, Longet, S, Tonry, C, Roarty, C, Watson, C, Amirthalingam, G, Vichos, I, Morey, E, Douglas, NL, Marinou, S, Plested, E, Aley, PK, Galiza, E, Faust, SN, Hughes, S, Murray, C, Roderick, MR, Shackley, F, Oddie, S, Lee, TWR, Turner, DPJ, Raman, M, Owens, S, Turner, PJ, Cockerill, H, Lopez Bernal, J, Ijaz, S, Poh, J, Shute, J, Linley, E, Borrow, R, Hoschler, K, Brown, KE, Carroll, MW, Klenerman, P, Dunachie, SJ, Ramsay, M, Voysey, M, Waterfield, T, Snape, MD
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Elsevier 2023

Ижил төстэй зүйлс

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
-н: Helen Ratcliffe, зэрэг
Хэвлэсэн: (2023-12-01)

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021
-н: Ratcliffe, H, зэрэг
Хэвлэсэн: (2022)

The Role of Intestinal Epithelial Permeability in Multisystem Inflammatory Syndrome in Children: A Case–Control Study
-н: Cathal Roarty, зэрэг
Хэвлэсэн: (2024-08-01)

PANDEMIC HUMAN CORONAVIRUS – CHARACTERIZATION AND COMPARISON OF SELECTED PROPERTIES OF HCOV-SARS AND HCOV-MERS
-н: Katarzyna W. Pancer
Хэвлэсэн: (2018-06-01)

Development of Primer Panels for Whole-Genome Amplification and Sequencing of Human Seasonal Coronaviruses: hCoV-OC43, hCoV-HKU1, hCoV-229E, and hCoV-NL63
-н: Tamila Musaeva, зэрэг
Хэвлэсэн: (2024-12-01)

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study [version 2; peer review: 2 approved]
-н: Robert W. Aldridge, зэрэг
Хэвлэсэн: (2020-12-01)

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
-н: Virginia Fuochi, зэрэг
Хэвлэсэн: (2023-03-01)

Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China
-н: Li-Jin Cui, зэрэг
Хэвлэсэн: (2011-01-01)

Seroconversion to HCoV-NL63 in Rhesus Macaques
-н: Lia van der Hoek, зэрэг
Хэвлэсэн: (2009-10-01)

HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia
-н: Lida Carolina Lesmes-Rodríguez, зэрэг
Хэвлэсэн: (2024-08-01)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
-н: Sean A. Lynch, зэрэг
Хэвлэсэн: (2021-08-01)

The transcriptional and translational landscape of HCoV-OC43 infection.
-н: Stefan Bresson, зэрэг
Хэвлэсэн: (2025-01-01)

Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
-н: Yongkang Chen, зэрэг
Хэвлэсэн: (2022-04-01)

Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
-н: Jiangchao Xiang, зэрэг
Хэвлэсэн: (2022-11-01)

55: DEVELOPMENT OF A NOVEL IN-VITRO HCOV-OC43 SCREENING METHOD
-н: S. Haynes, зэрэг
Хэвлэсэн: (2022-11-01)

The human coronavirus HCoV-229E S-protein structure and receptor binding
-н: Zhijie Li, зэрэг
Хэвлэсэн: (2019-10-01)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
-н: Martin Dugas, зэрэг
Хэвлэсэн: (2021-04-01)

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
-н: Alvaro A. Ordonez, зэрэг
Хэвлэсэн: (2022-03-01)

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
-н: Yongmei Feng, зэрэг
Хэвлэсэн: (2022-12-01)

Utilizing HCoV-OC43 to better understand the neurological impact of COVID-19
-н: Catherine LaCourse
Хэвлэсэн: (2024-12-01)

HCoV‐HKU1 and TMPRSS2 interaction: uncovering mechanisms of viral invasion
-н: Zehan Pang, зэрэг
Хэвлэсэн: (2025-01-01)

Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
-н: Jang Hoon Kim, зэрэг
Хэвлэсэн: (2023-12-01)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
-н: Sophie Steiner, зэрэг
Хэвлэсэн: (2020-12-01)

Co-circulation of Four Human Coronaviruses (HCoVs) in Queensland Children with Acute Respiratory Tract Illnesses in 2004
-н: Theo P. Sloots, зэрэг
Хэвлэсэн: (2012-04-01)

Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
-н: Yongmei Feng, зэрэг
Хэвлэсэн: (2024-12-01)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
-н: Jing Yang, зэрэг
Хэвлэсэн: (2020-08-01)

Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry
-н: Huan Sun, зэрэг
Хэвлэсэн: (2020-01-01)

Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro
-н: Sébastien Pasquereau, зэрэг
Хэвлэсэн: (2021-02-01)

Disinfection Effect of High-pressure Carbon Dioxide on Human Coronavirus (hCoV-229E)
-н: Peng NING, зэрэг
Хэвлэсэн: (2023-01-01)

A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs
-н: Peifang Xie, зэрэг
Хэвлэсэн: (2022-05-01)

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
-н: Nehemya Friedman, зэрэг
Хэвлэсэн: (2018-09-01)

IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
-н: Gianfranco Politano, зэрэг
Хэвлэсэн: (2020-09-01)

ESCRT Protein VPS4A Is Required for the Formation of Replication Centers and Replication of Human Coronavirus 229E (HCoV-229E)
-н: Rinki Kumar, зэрэг
Хэвлэсэн: (2024-08-01)

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
-н: Irene A. Abela, зэрэг
Хэвлэсэн: (2024-02-01)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
-н: Darina Bačenková, зэрэг
Хэвлэсэн: (2021-02-01)

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
-н: Laura Thümmler, зэрэг
Хэвлэсэн: (2021-08-01)

Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
-н: Xiaohuan Wang, зэрэг
Хэвлэсэн: (2022-07-01)

Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes
-н: Xiyong Song, зэрэг
Хэвлэсэн: (2021-01-01)

Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
-н: Nehemya Friedman, зэрэг
Хэвлэсэн: (2021-01-01)

Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C
-н: Tiley, KS, зэрэг
Хэвлэсэн: (2022)